I suspect there is a certain investor resistance to the product on account of not understanding how it works. The answer to that is results, clinical results and commercial results. At least it means that it's cheap buying for those who enter now.
T2 diabetes - likely perfect target, page-10
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.2¢ | 7.2¢ | $3.325K | 46.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 114000 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 217134 | 4 |
View Market Depth
| Last trade - 10.56am 12/11/2024 (20 minute delay) ? |
| IMC (ASX) Chart |